Skip to main content

Table 5 Summary of total cost in USD by cost headings according to treatment alternatives

From: Economic evaluation of artesunate and three quinine regimens in the treatment of severe malaria in children at the Ebolowa Regional Hospital-Cameroon: a cost analysis

Cost headings ARTES
(n = 30)
QLD
(n = 28)
QNLD3
(n = 30)
  QNLD2
(n = 30)
 
Cost per group Cost per patient Cost per group Cost per patient p value Cost per group Cost per patient p value Cost per group Cost per patient p value
Anti-malaria drugs 231.57 7.72 67.68 2.42 <0.001 73.32 2.44 <0.001 78.96 2.63 <0.001
Nursing care materials 103.47 3.50 97.37 3.477 0.49 104.86 3.50 0.44 102.71 3.42 0.61
Adjuvant care materials 619.24 20.64 560.56 20.02 0.48 566.95 18.90 0.57 498.61 16.62 0.99
Laboratory Investigations 635.25 21.17 620.74 22.16 0.58 798.87 26.63 0.17 726.85 24.23 0.53
Admission 147.50 4.92 170 6.07 0.03 192.5 6.42 0.005 167.5 5.58 0.02
Professional fees 217.05 7.24 230.77 8.24 0.33 255.18 8.51 0.25 232.51 7.75 0.57
Total and mean cost per treatment alternative (95% CI) 1954.08 65.14 (57.68–72.60) 1747.12 62.40 (52.67–72.13) 0.21 1991.68 66.40 (57.03–75.77) 0.67 1807.14 60.23 (51.55–68.91) 0.24